Blog
MLO Survey Sheds Light on the Impact of COVID-19 on Molecular Diagnostics
April 5, 2024
In Medical Laboratory Observer’s (MLO-online.com) latest State of the Industry Survey, the focus is on molecular diagnostics and the impact of COVID-19.
The survey reveals how labs across the country are dealing with increased testing demands, what types of tests are preferred, and how the global pandemic has shaped daily lab procedures.
When asked to what degree have testing demands increased, 37 percent of the respondents estimated growth at 25 percent since the emergence of the SARS-CoV-2 virus. Another 24 percent of the respondents estimated increased demand by as much as 50 percent.
So how are labs dealing with this increased demand for lab testing? According to the survey, they are either sending overflow samples to other facilities for processing (51 percent) or they are internally taking steps to increase capacity by adding automation and more test options (48 percent).
When asked about their preference for which lab test to use for COVID-19, 70 percent of the respondents indicated they preferred reverse transcriptase quantitative polymerase chain reaction (rRT-qPCR) based on accuracy, reliability, and availability.
Click HERE for the survey results.
LigoLab’s Comprehensive Platform Gives Clinical Labs the Tools They Need
Is your laboratory struggling to keep up with the increased testing demands? Are the manual order entry and follow-up bottlenecks affecting your lab’s testing capacity and turnaround times? Does your laboratory information system (LIS in healthcare, also known as LIS software) have the agility, automation, and end-to-end interoperability needed to meet the demands for effective and efficient testing and reporting?
From patient registration to reporting, the LigoLab LIS & RCM Informatics Platform and the TestDirectly Direct-to-Consumer Lab Testing Portal (TestDirectly.com) have you covered.
The LigoLab platform has the limitless configuration and automation to support high-volume pooled testing as a screening tool for COVID-19, and the TestDirectly Direct-to-Consumer Lab Testing Portal is a web-based application that can quickly interface with any LIS software to create end-to-end efficiencies in both the laboratory and at the collection site.
More LigoLab Resources
Our Story - a LigoLab Presentation
How to Increase Total Revenue Without Adding Operating Costs
Operational Excellence - It’s Possible With the Right Laboratory Operating Platform
More TestDirectly Resources
How TestDirectly Helped DuPage County Create a More Efficient Drive-Through With Faster Test Results
How Our Lab Partner Embraced Innovation and Won a Statewide Testing Contract
In Latin, “Ligo” means to unite or connect, at that’s precisely what LigoLab does for its laboratory partners, transforming them into information-driven, connected, and thriving businesses with its enterprise healthcare software solutions.
